# Sequential Expansion of Comparative Effectiveness of Anticoagulants

> **NCT02081807** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 221228 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02081807
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-07
- **Primary completion:** 2017-11-01
- **Final completion:** 2017-11-01
- **Target enrollment:** 221228 (ACTUAL)
- **Last updated:** 2019-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02081807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02081807, "Sequential Expansion of Comparative Effectiveness of Anticoagulants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02081807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*